Overall, the herein reported VH CDR3-focused SHM, present in all patients of our cohort, may imply that U-CLL BcR IG may diversify post-transformation through ongoing antigen interactions critically mediated via the VH CDR3 region. This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.